Munafa Stock Market Course + Intraday & FNO calls 
Outlook Therapeutics (OTLK) Technical (Analysis) Reports Outlook Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Outlook Therapeutics (OTLK)
Technical Analysis Report for USA stock OTLK Outlook Therapeutics. Dated: 30 Jan 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock OTLK Outlook Therapeutics then click here. or read Experts views on Outlook Therapeutics or Forecast & share price targets of Outlook Therapeutics
Outlook Therapeutics Opened at 0.46 and Closed at: 0.43, which is -6.98% of previous session's close. It moved within a range of 0.43 and 0.47
The session was a Bearish session with an average volume of 1406563, which is -74.43% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
Support for tomorrow is 0.41 and resistance for tomorrow is 0.45
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 0.42, 0.4 resistance for tomorrow's hourly charts is 0.46, 0.48
10 Day SMA for Outlook Therapeutics (OTLK) is 0.5 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Outlook Therapeutics (OTLK) is 0.53 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Outlook Therapeutics (OTLK) is 1.38 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 1.29 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Outlook Therapeutics is 1.54 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Outlook Therapeutics is at 0.53 and 200 DMA is at 1.54, while 50 DMA and 100 DMA are at 1.38 and 1.29 respectively
Outlook Therapeutics (OTLK) moving average of 20 SMA is at 0.53 and 20 EMA is at 0.69
| Date | Closing Price | 20 SMA | 20 EMA |
| 30 Fri Jan | 0.43 | 0.53 | 0.69 |
| 29 Thu Jan | 0.46 | 0.59 | 0.72 |
| 28 Wed Jan | 0.45 | 0.66 | 0.75 |
| 27 Tue Jan | 0.50 | 0.74 | 0.78 |
| 26 Mon Jan | 0.51 | 0.8 | 0.81 |
| 23 Fri Jan | 0.51 | 0.87 | 0.84 |
Outlook Therapeutics (OTLK) moving average of 50 SMA is at 1.38 and 50 EMA is at 1.06
| Date | Closing Price | 50 SMA | 50 EMA |
| 30 Fri Jan | 0.43 | 1.38 | 1.06 |
| 29 Thu Jan | 0.46 | 1.4 | 1.09 |
| 28 Wed Jan | 0.45 | 1.43 | 1.12 |
| 27 Tue Jan | 0.50 | 1.45 | 1.15 |
| 26 Mon Jan | 0.51 | 1.46 | 1.18 |
| 23 Fri Jan | 0.51 | 1.48 | 1.21 |
Outlook Therapeutics (OTLK) moving average of 100 SMA is at 1.29 and 100 EMA is at 1.32
| Date | Closing Price | 100 SMA | 100 EMA |
| 30 Fri Jan | 0.43 | 1.29 | 1.32 |
| 29 Thu Jan | 0.46 | 1.3 | 1.34 |
| 28 Wed Jan | 0.45 | 1.3 | 1.36 |
| 27 Tue Jan | 0.50 | 1.31 | 1.38 |
| 26 Mon Jan | 0.51 | 1.31 | 1.4 |
| 23 Fri Jan | 0.51 | 1.31 | 1.42 |
Outlook Therapeutics (OTLK) moving average of 200 SMA is at 1.54 and 200 EMA is at 1.87
| Date | Closing Price | 200 SMA | 200 EMA |
| 30 Fri Jan | 0.43 | 1.54 | 1.87 |
| 29 Thu Jan | 0.46 | 1.55 | 1.88 |
| 28 Wed Jan | 0.45 | 1.55 | 1.89 |
| 27 Tue Jan | 0.50 | 1.56 | 1.9 |
| 26 Mon Jan | 0.51 | 1.56 | 1.91 |
| 23 Fri Jan | 0.51 | 1.56 | 1.92 |
Zimmer Biomet has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Zimmer Biomet, about 31.57% more returns!
Smith Nephew has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Smith Nephew, about 38.68% more returns!
Perrigo Company has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Perrigo Company, about 37.15% more returns!
3m Company has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in 3m Company, about 29.5% more returns!
Cigna Corporation has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Cigna Corporation, about 33.06% more returns!
Vtv Therapeutics has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Vtv Therapeutics, about 24.27% more returns!
Sarepta Therapeutics has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Sarepta Therapeutics, about 30.3% more returns!
Syndax Pharmaceuticals has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Syndax Pharmaceuticals, about 30.25% more returns!
Sellas Life has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Sellas Life, about 21.52% more returns!
Quidel Corporation has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Quidel Corporation, about 29.26% more returns!
Meiragtx Holdings has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Meiragtx Holdings, about 32.29% more returns!
Madrigal Pharmaceuticals has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Madrigal Pharmaceuticals, about 17.24% more returns!
Iterum Therapeutics has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Iterum Therapeutics, about 34.85% more returns!
Iradimed Corporation has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Iradimed Corporation, about 37.34% more returns!
Idexx Laboratories has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Idexx Laboratories, about 34.92% more returns!
Hologic Inc has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Hologic Inc, about 35.35% more returns!
Amicus Therapeutics has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Amicus Therapeutics, about 34.99% more returns!
Ardelyx Inc has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Ardelyx Inc, about 59.89% more returns!
Angiodynamics Inc has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Angiodynamics Inc, about 16.55% more returns!
Outlook Therapeutics Technical analysis of indicators
Price action analysis of Outlook Therapeutics (OTLK) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Outlook Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Outlook Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Outlook Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Outlook Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Outlook Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.49 and Outlook Therapeutics OTLK stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Outlook Therapeutics OTLK stock. Volume based technical analysis of Outlook Therapeutics OTLK stock is negative.
Outlook Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock OTLK Outlook Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And OTLK Experts View which covers a lot of information including buying and selling signals
OTLK future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Outlook Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Outlook Therapeutics (OTLK) Technical (Analysis) Reports Outlook Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
